Understand Defence Against Disease - IB Biology

SECTION 1

Historical Context & Motivation

For most of human history, infectious diseases were the leading cause of death, and people had almost no understanding of why illness struck. Ancient civilizations attributed disease to angry gods, poisonous vapors called miasma, or imbalances in bodily fluids. It was not until scientists began studying the microscopic world that the true causes of disease — and the body's remarkable defences against them — came into focus.

1796 • Jenner's Smallpox Vaccine

Edward Jenner inoculated a boy with cowpox material, demonstrating that exposure to a related, milder pathogen could protect against smallpox. This laid the foundation for vaccination.

1861 • Germ Theory of Disease

Louis Pasteur provided experimental evidence that microorganisms cause disease, overturning the miasma theory and launching the field of microbiology.

1882 • Koch's Postulates

Robert Koch established a set of criteria to prove that a specific microorganism causes a specific disease. His work on tuberculosis and anthrax became the gold standard for identifying pathogens.

1928 • Discovery of Penicillin

Alexander Fleming noticed that a mold (Penicillium) killed bacteria on a culture plate, leading to the development of the first widely used antibiotic.

1980 • Eradication of Smallpox

The World Health Organization declared smallpox eradicated — the first human disease eliminated through a global vaccination campaign, proving the power of herd immunity.

These breakthroughs revealed a central question in biology: how does the human body defend itself against the enormous variety of pathogens it encounters every day? The answer involves multiple layers of defence, from physical barriers that block entry, to specialized cells that hunt and destroy invaders. Understanding these layers is essential for topics ranging from vaccine design to autoimmune disorders.

SECTION 2

Core Principles of Defence Against Disease

The body's defence against disease can be divided into broad categories. First, non-specific defences (also called innate immunity) act as the body's general-purpose shield — they respond the same way regardless of the pathogen. Second, specific defences (also called adaptive immunity) are tailored to individual pathogens and improve with repeated exposure. Together, these systems form an integrated, multi-layered strategy.

Primary Physical & Chemical Barriers

The skin, mucous membranes, stomach acid, and lysozyme in tears and saliva form the first line of defence, preventing pathogen entry before infection begins.

Innate Immune Response

If pathogens breach the barriers, phagocytes (such as macrophages and neutrophils) engulf and digest them. Inflammation and fever are also part of this rapid, non-specific second line of defence.

Adaptive Immune Response

Lymphocytes — specifically B cells and T cells — mount a targeted attack using antibodies and cell-mediated responses. This is the third line of defence.

Immunological Memory

After an infection, memory cells persist in the body. If the same pathogen returns, the immune response is faster and stronger — this is the basis for vaccination and long-term immunity.

Antigens & Antibodies

Pathogens carry unique surface molecules called antigens. The immune system produces Y-shaped antibodies with complementary binding sites that lock onto specific antigens with extreme precision.

✦

KEY TAKEAWAY

Think of the body's defences like airport security. The outer walls and locked doors are like the skin — they stop most threats from even getting in. The general security guards (phagocytes) patrol for anything suspicious, regardless of who the intruder is. Finally, specialized detectives (lymphocytes) study each threat's unique identity, track it down, and remember its face for next time.

SECTION 3

Visual Overview: Three Lines of Defence

This diagram shows the three lines of defence in order. The first line (top) consists of physical and chemical barriers that prevent pathogen entry. If breached, the second line (middle) activates a rapid, non-specific response. The third line (bottom) mounts a targeted, antigen-specific attack and creates immunological memory.

Notice how each line of defence escalates in specificity and complexity. The first line is always active and requires no activation — skin is always present, stomach acid is always acidic. The second line activates within hours of a breach, recruiting cells that recognise general patterns shared by many pathogens (such as bacterial cell wall components). The third line takes days to fully mobilize during a first infection, but its precision and memory make it the most powerful long-term defence.

SECTION 4

How the Immune System Works: Mechanisms in Detail

Phagocytosis: The Innate Response in Action

When pathogens cross the body's barriers, phagocytosis is one of the first cellular responses triggered. Phagocytes — including macrophages and neutrophils — are white blood cells that engulf and digest foreign particles. The process begins when a phagocyte recognises molecular patterns on the pathogen's surface. The phagocyte extends its cell membrane around the pathogen, engulfing it into a vesicle called a phagosome. The phagosome then fuses with a lysosome, and digestive enzymes break down the pathogen.

Antigen Presentation: Bridging Innate and Adaptive Immunity

After digesting a pathogen, phagocytes (especially macrophages and dendritic cells) present fragments of the pathogen — antigens — on their surface using proteins called MHC (major histocompatibility complex) molecules. These antigen-presenting cells act as messengers, carrying information about the invader to the adaptive immune system. When a helper T cell with the matching receptor encounters the presented antigen, it becomes activated, triggering a cascade of specific immune responses.

Humoral vs. Cell-Mediated Immunity

The adaptive immune response operates through two major arms. Humoral immunity involves B lymphocytes that, once activated by helper T cells, differentiate into plasma cells. Plasma cells secrete large quantities of antibodies — Y-shaped proteins that bind to specific antigens on pathogens. This binding can neutralize toxins, prevent pathogens from entering cells, or tag them for destruction by other immune cells (a process called opsonization). Cell-mediated immunity involves killer T cells (cytotoxic T lymphocytes) that directly destroy body cells that have been infected by viruses or have become cancerous.

This flowchart traces the adaptive immune response from pathogen encounter to outcome. After a macrophage presents the antigen to a helper T cell, two branches activate: B cells produce antibodies (humoral), while killer T cells destroy infected cells (cell-mediated). Memory cells enable a faster secondary response.

SECTION 5

Types of Immunity & Antibody Function

Active vs. Passive Immunity

Immunity can be classified by how it is acquired. Active immunity develops when your own immune system encounters an antigen and produces antibodies and memory cells. This can happen naturally (by catching a disease) or artificially (through vaccination). Active immunity is long-lasting because memory cells persist for years or even a lifetime. In contrast, passive immunity is acquired when pre-formed antibodies are transferred from another organism. Natural passive immunity occurs when a mother's antibodies cross the placenta to her fetus or pass through breast milk. Artificial passive immunity involves injecting antibodies (such as antivenom for a snake bite). Passive immunity provides immediate protection but is temporary because no memory cells are formed.

Feature	Active Immunity	Passive Immunity
How acquired	Body produces its own antibodies after antigen exposure	Pre-formed antibodies received from another source
Natural example	Recovering from chickenpox	Maternal antibodies via placenta or breast milk
Artificial example	Vaccination (e.g., MMR, COVID-19)	Injection of antiserum or monoclonal antibodies
Speed of protection	Slow (days to weeks to develop)	Immediate
Duration	Long-lasting (years to lifetime)	Short-lived (weeks to months)
Memory cells formed?	Yes	No

Comparison of active and passive immunity

How Antibodies Work

Antibodies (also called immunoglobulins) are Y-shaped glycoproteins. Each antibody has two identical antigen-binding sites at the tips of the Y that are complementary in shape to a specific antigen — this is the lock-and-key principle of specificity. Antibodies combat pathogens in several ways: they can neutralize pathogens by blocking their surface molecules, agglutinate (clump) pathogens together so phagocytes can engulf many at once, or opsonize them — coating the pathogen surface to enhance phagocyte recognition.

💡

IB Exam Tip

Remember that each antibody is specific to one antigen. The IB frequently tests whether you understand that the specificity arises from the shape of the variable region at the tips of the Y-shaped molecule. Use the term "complementary" in your answers to describe how the antibody fits the antigen.

SECTION 6

Worked Example: Tracing the Immune Response to a Bacterial Infection

Let's trace what happens when a student gets a small cut on their hand and bacteria from the soil enter the wound. This example walks through each line of defence in sequence.

Bacterial Infection Through a Skin Cut

1
Step 1 — First Line of Defence is Breached

The skin, which is the primary physical barrier, has been broken by the cut. The first line of defence has failed at the site of the wound. Blood clotting begins to seal the opening, but bacteria have already entered the underlying tissue.

Barrier breached → pathogens enter tissue.
2
Step 2 — Inflammatory Response (Second Line)

Damaged cells at the wound site release chemical signals called histamines and cytokines. These cause local blood vessels to dilate (vasodilation), increasing blood flow to the area. The area becomes red, warm, and swollen — classic signs of inflammation. Increased permeability of capillary walls allows phagocytes to squeeze through into the infected tissue.

Inflammation recruits phagocytes to the site of infection.
3
Step 3 — Phagocytosis (Second Line)

Neutrophils arrive first and begin engulfing bacteria by phagocytosis. Macrophages follow and not only digest pathogens but also present bacterial antigens on their surfaces using MHC class II molecules. These macrophages now function as antigen-presenting cells (APCs).

Bacteria digested; antigens presented to activate adaptive immunity.
4
Step 4 — Helper T Cell Activation (Third Line)

An antigen-presenting macrophage migrates to the nearest lymph node, where it encounters helper T cells. If a helper T cell has a receptor complementary to the presented antigen, it becomes activated. The activated helper T cell divides rapidly (clonal selection) and releases cytokines that activate both B cells and killer T cells.

Helper T cells activate B cells and killer T cells specific to this pathogen.
5
Step 5 — Antibody Production and Memory

Activated B cells with receptors complementary to the bacterial antigen differentiate into plasma cells, which secrete large quantities of antibodies into the blood and tissue fluid. These antibodies bind to the bacteria, neutralizing them, clumping them together, and tagging them for phagocytosis. Some B and T cells become memory cells, which persist long after the infection clears. If the same bacteria enter the body again, these memory cells enable a much faster and stronger secondary immune response.

Infection cleared. Memory cells provide long-term protection against re-infection.

SECTION 7

Strengths & Limitations of Each Line of Defence

Each line of defence has distinct strengths and weaknesses. Understanding these helps explain why all three layers are necessary and why certain diseases are more dangerous than others.

Defence Line	Strengths	Limitations
1st Line: Barriers	Always active; no energy cost; effective against almost all types of pathogens simultaneously	Can be breached by cuts, burns, or surgical procedures; cannot adapt to new threats
2nd Line: Innate	Rapid response (hours); recognises broad categories of pathogens; does not need prior exposure	Non-specific — same response every time; inflammation can damage own tissue; no memory
3rd Line: Adaptive	Highly specific to individual pathogens; creates memory for long-term protection; can improve with each exposure	Slow primary response (days to weeks); requires antigen presentation from innate system; can malfunction (autoimmune disease, allergies)

Strengths and limitations of the three lines of defence

✦

KEY TAKEAWAY

Think of your immune defences like a country's military strategy. The border walls and fences (first line) stop most threats passively. If intruders get through, rapid-response forces (second line) are deployed quickly to deal with any threat, though they don't distinguish one enemy from another. For sophisticated, persistent threats, intelligence agents and special forces (third line) study the enemy, develop targeted weapons, and maintain files so they can respond instantly to any future encounter.

SECTION 8

Vaccination, Antibiotic Resistance & Beyond

How Vaccines Exploit Immunological Memory

Vaccines work by introducing a harmless form of an antigen — such as an inactivated pathogen, an attenuated (weakened) live pathogen, or a fragment of a pathogen's protein — to stimulate an adaptive immune response without causing the disease. The immune system produces antibodies and, crucially, memory cells. If the real pathogen is encountered later, these memory cells enable a rapid secondary response that overwhelms the pathogen before symptoms develop. This principle underpins all major vaccination programs.

Concept	IB Biology Level	Advanced / HL Extension
Primary immune response	Slow; lower antibody levels; mainly IgM produced	Clonal selection of naïve B cells; class switching from IgM to IgG over time
Secondary immune response	Faster and stronger; more antibodies produced; prevents disease symptoms	Memory B cells rapidly differentiate to plasma cells; affinity maturation produces higher-quality antibodies
Antibiotic resistance	Overuse of antibiotics selects for resistant bacteria through natural selection	Horizontal gene transfer (plasmids); biofilm formation; multi-drug resistance (MDR) mechanisms
Monoclonal antibodies	Artificially produced antibodies used in pregnancy tests, diagnostics, and some treatments	Hybridoma technology; therapeutic uses in cancer (e.g., trastuzumab) and autoimmune diseases

IB standard vs. advanced concepts in immunity

As you move into HL Biology or university-level immunology, you will encounter the molecular details of T cell receptor diversity, cytokine signaling networks, and the mechanisms behind immune disorders such as autoimmune diseases (where the immune system attacks the body's own cells) and immunodeficiency (where the immune system fails to function adequately, as in HIV/AIDS). The principles you have learned here — barriers, innate immunity, adaptive immunity, and memory — form the foundation for understanding all of these advanced topics.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

Explain why the skin is considered part of the first line of defence, and describe two other examples of non-specific barriers that prevent pathogen entry.

Show answer

The skin is part of the first line of defence because it acts as a continuous physical barrier that blocks pathogens from entering the body. Its outer layer of dead, keratinized cells is difficult for most microorganisms to penetrate, and its slightly acidic surface inhibits bacterial growth. Two other examples are mucous membranes, which line the respiratory and digestive tracts and trap pathogens in sticky mucus, and stomach acid (hydrochloric acid at pH 1.5–3.5), which chemically destroys most ingested bacteria. These are all non-specific because they work against all pathogens equally, without targeting any particular organism.

Question 2: BASIC CALCULATION

During a primary immune response, a patient's blood antibody concentration reaches 50 arbitrary units (AU) after 14 days. During a secondary immune response to the same pathogen, the antibody concentration reaches 500 AU after only 3 days. Calculate the fold increase in peak antibody concentration and the fold decrease in response time between the primary and secondary responses.

Show answer

The fold increase in peak antibody concentration is 500 AU ÷ 50 AU = 10-fold higher. The fold decrease in response time is 14 days ÷ 3 days ≈ 4.7-fold faster. This dramatic improvement in both speed and magnitude is due to the presence of memory B cells and memory T cells created during the primary response. When the same antigen is encountered again, these memory cells are rapidly activated and undergo clonal expansion, producing far more plasma cells (and therefore antibodies) in a much shorter time frame.

Question 3: INTERMEDIATE

A macrophage engulfs a bacterium and presents its antigens on MHC class II molecules. Describe the sequence of events that leads from this antigen presentation to the production of antibodies by plasma cells. Include the roles of helper T cells and B cells in your answer.

Show answer

After the macrophage presents the bacterial antigen on its MHC class II molecule, a helper T cell with a complementary T cell receptor (TCR) recognizes and binds to the antigen-MHC complex. This activates the helper T cell, which begins to divide (clonal expansion) and secrete cytokines. These cytokines activate B cells that have also bound the same antigen via their surface antibodies (B cell receptors). The activated B cells undergo clonal expansion and differentiate into two types of cells: plasma cells and memory B cells. Plasma cells are effector cells that secrete large quantities of antibodies specific to the bacterial antigen into the blood and tissue fluid. These antibodies then bind to the bacteria, neutralizing them, clumping them (agglutination), and marking them for enhanced phagocytosis (opsonization).

Question 4: APPLIED

A new strain of influenza virus emerges with significantly mutated surface antigens (hemagglutinin and neuraminidase). Explain why a person who recovered from last year's flu may still become ill with the new strain, even though they developed immunity to the previous strain. How does this relate to the need for annual flu vaccinations?

Show answer

Adaptive immunity is highly specific: the antibodies and memory cells produced during last year's infection recognize the specific shape of last year's hemagglutinin and neuraminidase antigens. When the virus mutates these surface proteins significantly (a process called antigenic shift or antigenic drift), the existing antibodies can no longer bind effectively to the new antigens. The memory cells from the previous infection fail to recognize the new strain, so the immune system must mount a primary immune response from scratch, which is slower and less effective. This is why the person can become ill again. Annual flu vaccinations are necessary because scientists predict which strains are most likely to circulate and update the vaccine antigens accordingly, allowing the immune system to develop memory cells targeted at the new surface proteins before natural exposure occurs.

Question 5: CRITICAL THINKING

HIV (Human Immunodeficiency Virus) specifically targets and destroys helper T cells. Using your understanding of the immune system, explain why the destruction of helper T cells leads to the collapse of the entire adaptive immune response. Discuss both humoral and cell-mediated immunity in your answer, and explain why AIDS patients become vulnerable to opportunistic infections.

Show answer

Helper T cells are the central coordinators of the adaptive immune response. They serve as the essential link between the innate and adaptive systems: after antigen presentation by a macrophage or dendritic cell, helper T cells must be activated before they can, in turn, activate both B cells (for humoral immunity) and killer T cells (for cell-mediated immunity). When HIV destroys helper T cells, B cells cannot be properly stimulated to differentiate into plasma cells, so antibody production drops dramatically. Similarly, killer T cells are not activated to destroy virus-infected or cancerous cells. As the helper T cell count falls (measured as CD4⁺ count), the patient's immune system progressively loses its ability to mount specific responses to any pathogen. Opportunistic infections — diseases caused by microorganisms that a healthy immune system would normally control easily, such as Pneumocystis pneumonia or Candida infections — can then take hold because neither the humoral nor the cell-mediated branch of adaptive immunity is functional. The innate immune system alone is insufficient to control these infections without the amplification and coordination that helper T cells provide.

SUMMARY

Lesson Summary

Summary

The body defends against disease through three integrated layers. The first line of defence consists of physical and chemical barriers — including the skin, mucous membranes, stomach acid, and lysozyme — that prevent pathogen entry. If breached, the second line (innate immunity) provides a rapid, non-specific response through phagocytosis, inflammation, and fever. The third line (adaptive immunity) is antigen-specific, involving B lymphocytes that produce antibodies (humoral immunity) and T lymphocytes that coordinate and carry out cell-mediated killing.

A hallmark of adaptive immunity is immunological memory: memory cells persist after infection and enable a faster, stronger secondary immune response upon re-exposure. Vaccination exploits this memory by safely exposing the body to antigens without causing disease. Understanding the distinction between active immunity (body makes its own antibodies) and passive immunity (antibodies received from another source) is essential for IB exam success and for appreciating real-world public health strategies.